Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ: DMAA · Real-Time Price · USD
10.90
0.00 (0.00%)
Nov 16, 2026, 4:00 PM EST - Market closed
DMAA Market Cap
DMAA has a market cap or net worth of $264.62 million as of November 16, 2026. It is the 18,762nd most valuable company in the world and the 3,290th biggest in the United States. Its market cap has decreased by 23.55% in one year.
Market Cap
264.62M
Enterprise Value
264.95M
1-Year Change
-23.55%
Global Rank
Country Rank
#3,290 United States
Category
ChartMarket Cap Chart
Since the IPO on January 28, 2025, DMAA's market cap has decreased from $291.71M to $264.62M, a decrease of -9.29%. That is a compound annual growth rate of -5.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 264.62M | -23.90% |
| Dec 30, 2025 | 347.71M | 19.20% |
| Jan 28, 2025 | 291.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NewHold Investment Corp IV | 274.47M |
| Southport Acquisition Corp. II | 272.25M |
| Dynamix Corporation III | 271.82M |
| Xterax Corporation II | 267.98M |
| FACT II Acquisition | 267.54M |
| Catalyst Acquisition | 266.27M |
| Oaktree Acquisition Corp. III Life Sciences | 263.04M |
| Newbury Street II Acquisition | 262.63M |